Table 4.

Comparison between LV function, ECV and myocardial strain before and after 6-months anti-hypertension drug therapy

	Before treatment	After treatment	P value
EF	44.6 ± 22.3	52.4 ± 18.9	0.02
LVEDVI (ml/m2)	96.9 (67.7)	74.8 (40.1)	0.06
LVSVI (ml/m2)	40.0 ± 16.4	40.1 ± 13.8	0.85
LVMI(g/m2)	106.5 (31.2)	97.6 (36.2)	0.18
EDWT (cm)	1.2 (0.2)	1.1 (0.3)	0.03
ECV
Mean	0.27 (0.04)	0.25 (0.04)	0.000
Base	0.29 ± 0.04	0.25 ± 0.04	0.000
Middle	0.25 (0.01)	0.24 (0.01)	0.001
Apex	0.25 (0.01)	0.24 (0.01)	0.71
RS
Global	16.8 ± 8.9	22.7 ± 9.5	0.01
Base	20.7 ± 11.1	29.5 ± 16.7	0.06
Middle	11.0 (17.0)	20.2 (14.3)	0.027
Apex	13.6 (17.9)	20.4 (22.3)	0.64
CS
Global	−13.4 ± 5.6	−16.0 ± 4.6	0.03
Base	−9.9 (10.5)	−10.9 (7.8)	0.02
Middle	−12.0 (11.9)	−17.4 (8.3)	0.16
Apex	−16.2 ± 6.5	−19.6 ± 5.2	0.05
LS
Global	−6.9 (6.0)	−9.0 (5.4)	1.00
Base	−5.4 (5.0)	−5.2 (13.1)	0.13
Middle	−6.4 (6.4)	−8.7 (5.8)	0.50
Apex	−10.7 (8.0)	−12.0 (6.3)	0.12